theophylline has been researched along with Alcohol Drinking in 13 studies
Alcohol Drinking: Behaviors associated with the ingesting of ALCOHOLIC BEVERAGES, including social drinking.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The pharmacokinetic profiles of three oral sustained-release theophylline preparations in steady state (350 mg Theograd, 350 mg Theolair Retard [= Nuelin Retard], and 300 mg Theolin Retard [= Theodur]) were compared in a group of six normal subjects and six patients with moderately severe asthmatic bronchitis." | 7.67 | Pharmacokinetics and pharmacodynamics of three sustained-release theophylline preparations (350 mg Theograd, 350 mg Theolair Retard and 300 mg Theodur) in steady state in healthy volunteers and asthmatics--Part I: Theophylline plasma levels. ( Drost, RH; Kreukniet, J; Maes, RA; van der Vet, AP, 1984) |
| "Acetaldehyde formation was determined by GC-FID analysis in the head space of incubation mixtures." | 5.31 | Rat ventral prostate xanthine oxidase bioactivation of ethanol to acetaldehyde and 1-hydroxyethyl free radicals: analysis of its potential role in heavy alcohol drinking tumor-promoting effects. ( Castro, GD; Castro, JA; Costantini, MH; Delgado de Layño, AM, 2001) |
| " Oxidative drug metabolizing capacity has been assessed by oral antipyrine and/or theophylline tests in consecutive patients with chronic pancreatitis (CP; alcoholic 24, idiopathic 47), acute pancreatitis (AP; 28) and pancreatic cancer (CA; 11)." | 5.06 | Factors contributing to the accelerated clearance of theophylline and antipyrine in adults with exocrine pancreatic disease. ( Acheson, DW; Braganza, JM; Houston, JB; Hunt, LP; Rose, P, 1989) |
| "The pharmacokinetic profiles of three oral sustained-release theophylline preparations in steady state (350 mg Theograd, 350 mg Theolair Retard [= Nuelin Retard], and 300 mg Theolin Retard [= Theodur]) were compared in a group of six normal subjects and six patients with moderately severe asthmatic bronchitis." | 3.67 | Pharmacokinetics and pharmacodynamics of three sustained-release theophylline preparations (350 mg Theograd, 350 mg Theolair Retard and 300 mg Theodur) in steady state in healthy volunteers and asthmatics--Part I: Theophylline plasma levels. ( Drost, RH; Kreukniet, J; Maes, RA; van der Vet, AP, 1984) |
| "Theophylline matrix cores were coated in a fluid bed with blends of the aqueous ethylcellulose dispersion "Aquacoat®ECD30" and guar gum." | 1.39 | Ethanol-resistant ethylcellulose/guar gum coatings--importance of formulation parameters. ( Chokshi, R; Leclercq, B; Muschert, S; Rosiaux, Y; Siepmann, F; Siepmann, J; Velghe, C, 2013) |
| "Acetaldehyde formation was determined by GC-FID analysis in the head space of incubation mixtures." | 1.31 | Rat ventral prostate xanthine oxidase bioactivation of ethanol to acetaldehyde and 1-hydroxyethyl free radicals: analysis of its potential role in heavy alcohol drinking tumor-promoting effects. ( Castro, GD; Castro, JA; Costantini, MH; Delgado de Layño, AM, 2001) |
| "1." | 1.29 | Metabolism of theophylline by cDNA-expressed human cytochromes P-450. ( Chen, J; Follath, F; Freiburghaus, AU; Ha, HR, 1995) |
| "Reliable methods for measuring serum theophylline levels have provided the clinician with a range of serum theophylline concentrations to maximize therapeutic results while minimizing potential adverse effects." | 1.29 | Clinical theophylline toxicity: acute and chronic. ( Byrd, RP; Lopez, P; Mercer, P; Roy, TM, 1993) |
| " After chronic administration of glucocorticoids, the rate of ethanol elimination was significantly increased, whereas blood acetate concentration showed a tendency to increase, but did not reach statistical significance." | 1.28 | The effect of glucocorticoids, beta-2-adrenoceptor agonists, theophylline and propranolol on the rate of ethanol elimination and blood acetate concentration in humans. ( Korri, UM, 1990) |
| " 4 A nomogram for aminophylline dosage or monitoring of serum theophylline levels would have prevented little of the toxicity observed in these patients, although these measures would ensure that therapeutic concentrations were attained, and might prevent life-threatening toxicity." | 1.26 | Oral sustained-release aminophylline in medical inpatients: factors related to toxicity and plasma theophylline concentrations. ( Eppel, ML; Mackay, A; Oliver, JS; Ramsay, LE, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (30.77) | 18.7374 |
| 1990's | 6 (46.15) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rosiaux, Y | 1 |
| Velghe, C | 1 |
| Muschert, S | 1 |
| Chokshi, R | 1 |
| Leclercq, B | 1 |
| Siepmann, F | 1 |
| Siepmann, J | 1 |
| Spector, SL | 1 |
| van der Vet, AP | 1 |
| Drost, RH | 1 |
| Kreukniet, J | 1 |
| Maes, RA | 1 |
| Ramsay, LE | 1 |
| Mackay, A | 1 |
| Eppel, ML | 1 |
| Oliver, JS | 1 |
| Ha, HR | 1 |
| Chen, J | 1 |
| Freiburghaus, AU | 1 |
| Follath, F | 1 |
| Byrd, RP | 1 |
| Lopez, P | 1 |
| Mercer, P | 1 |
| Roy, TM | 1 |
| Landi, MT | 1 |
| Zocchetti, C | 1 |
| Bernucci, I | 1 |
| Kadlubar, FF | 1 |
| Tannenbaum, S | 1 |
| Skipper, P | 1 |
| Bartsch, H | 1 |
| Malaveille, C | 1 |
| Shields, P | 1 |
| Caporaso, NE | 1 |
| Vineis, P | 1 |
| Miyamae, M | 1 |
| Camacho, SA | 1 |
| Zhou, HZ | 1 |
| Diamond, I | 1 |
| Figueredo, VM | 1 |
| Gatch, MB | 1 |
| Wallis, CJ | 1 |
| Lal, H | 1 |
| Castro, GD | 1 |
| Delgado de Layño, AM | 1 |
| Costantini, MH | 1 |
| Castro, JA | 1 |
| McGuigan, ME | 1 |
| Korri, UM | 1 |
| Acheson, DW | 1 |
| Hunt, LP | 1 |
| Rose, P | 1 |
| Houston, JB | 1 |
| Braganza, JM | 1 |
2 reviews available for theophylline and Alcohol Drinking
| Article | Year |
|---|---|
Reciprocal relationship between pregnancy and pulmonary disease. State of the art.
Topics: Adrenergic beta-Agonists; Alcohol Drinking; Anti-Anxiety Agents; Anti-Bacterial Agents; Anti-Infecti | 1984 |
Poisoning potpourri.
Topics: Acetaminophen; Age Factors; Alcohol Drinking; Antidepressive Agents, Tricyclic; Arrhythmias, Cardiac | 2001 |
1 trial available for theophylline and Alcohol Drinking
| Article | Year |
|---|---|
Factors contributing to the accelerated clearance of theophylline and antipyrine in adults with exocrine pancreatic disease.
Topics: Adult; Aged; Alcohol Drinking; Antipyrine; Enzyme Induction; Female; Humans; Male; Metabolic Clearan | 1989 |
10 other studies available for theophylline and Alcohol Drinking
| Article | Year |
|---|---|
Ethanol-resistant ethylcellulose/guar gum coatings--importance of formulation parameters.
Topics: Alcohol Drinking; Cellulose; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Stability; | 2013 |
Pharmacokinetics and pharmacodynamics of three sustained-release theophylline preparations (350 mg Theograd, 350 mg Theolair Retard and 300 mg Theodur) in steady state in healthy volunteers and asthmatics--Part I: Theophylline plasma levels.
Topics: Adult; Alcohol Drinking; Asthma; Biological Availability; Delayed-Action Preparations; Female; Human | 1984 |
Oral sustained-release aminophylline in medical inpatients: factors related to toxicity and plasma theophylline concentrations.
Topics: Administration, Oral; Adolescent; Age Factors; Aged; Airway Obstruction; Alcohol Drinking; Aminophyl | 1980 |
Metabolism of theophylline by cDNA-expressed human cytochromes P-450.
Topics: Alcohol Drinking; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2A6; C | 1995 |
Clinical theophylline toxicity: acute and chronic.
Topics: Adult; Alcohol Drinking; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Overdos | 1993 |
Cytochrome P4501A2: enzyme induction and genetic control in determining 4-aminobiphenyl-hemoglobin adduct levels.
Topics: Age Factors; Alcohol Drinking; Aminobiphenyl Compounds; Arylamine N-Acetyltransferase; Caffeine; Car | 1996 |
Alcohol consumption reduces ischemia-reperfusion injury by species-specific signaling in guinea pigs and rats.
Topics: Alcohol Drinking; Alcoholism; Animals; Blood Pressure; Coronary Circulation; Creatine Kinase; Diasto | 1998 |
The effects of adenosine ligands R-PIA and CPT on ethanol withdrawal.
Topics: Adenosine; Alcohol Drinking; Animals; Anti-Anxiety Agents; Central Nervous System Depressants; Ethan | 1999 |
Rat ventral prostate xanthine oxidase bioactivation of ethanol to acetaldehyde and 1-hydroxyethyl free radicals: analysis of its potential role in heavy alcohol drinking tumor-promoting effects.
Topics: Acetaldehyde; Alcohol Drinking; Allopurinol; Animals; Antimetabolites; Caffeine; Carcinogens; Chroma | 2001 |
The effect of glucocorticoids, beta-2-adrenoceptor agonists, theophylline and propranolol on the rate of ethanol elimination and blood acetate concentration in humans.
Topics: Acetates; Adolescent; Adult; Albuterol; Alcohol Drinking; Ethanol; Humans; Male; Metabolic Clearance | 1990 |